7,027 Shares in DaVita Inc. $DVA Purchased by Landscape Capital Management L.L.C.

Landscape Capital Management L.L.C. purchased a new stake in DaVita Inc. (NYSE:DVA) during the 2nd quarter, HoldingsChannel.com reports. The fund purchased 7,027 shares of the company’s stock, valued at approximately $1,563,000.

A number of other hedge funds have also added to or reduced their stakes in DVA. Fifth Third Bancorp boosted its position in shares of DaVita by 831.4% during the first quarter. Fifth Third Bancorp now owns 38,411 shares of the company’s stock valued at $5,903,000 after buying an additional 34,287 shares during the last quarter. Assenagon Asset Management S.A. raised its position in DaVita by 30.5% in the 2nd quarter. Assenagon Asset Management S.A. now owns 44,783 shares of the company’s stock valued at $9,963,000 after buying an additional 10,477 shares during the last quarter. SG Americas Securities LLC raised its position in DaVita by 27.4% in the 1st quarter. SG Americas Securities LLC now owns 212,293 shares of the company’s stock valued at $32,627,000 after buying an additional 45,609 shares during the last quarter. LSV Asset Management lifted its stake in DaVita by 1.1% during the 4th quarter. LSV Asset Management now owns 936,768 shares of the company’s stock valued at $106,426,000 after acquiring an additional 9,739 shares in the last quarter. Finally, BI Asset Management Fondsmaeglerselskab A S lifted its stake in DaVita by 63.5% during the 4th quarter. BI Asset Management Fondsmaeglerselskab A S now owns 86,000 shares of the company’s stock valued at $9,770,000 after acquiring an additional 33,394 shares in the last quarter. Institutional investors and hedge funds own 90.12% of the company’s stock.

Insiders Place Their Bets

In other DaVita news, insider Kathleen Alyce Waters sold 15,405 shares of the business’s stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $208.40, for a total value of $3,210,402.00. Following the transaction, the insider directly owned 109,194 shares in the company, valued at $22,756,029.60. The trade was a 12.36% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.90% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on DVA shares. Raymond James Financial set a $220.00 target price on shares of DaVita in a research note on Friday, August 7th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a $265.00 price target on shares of DaVita in a research report on Wednesday, August 5th. Truist Financial cut their price target on shares of DaVita from $250.00 to $215.00 and set a “hold” rating on the stock in a report on Friday, August 7th. TD Cowen upgraded shares of DaVita from a “hold” rating to a “buy” rating and increased their price objective for the company from $201.00 to $220.00 in a research note on Friday, August 7th. Finally, UBS Group lifted their target price on shares of DaVita from $235.00 to $270.00 and gave the stock a “buy” rating in a research report on Friday, July 10th. Four equities research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $221.75.

DaVita Trading Down 0.6%

DVA stock opened at $174.21 on Friday. The stock has a market cap of $11.11 billion, a P/E ratio of 14.26, a P/E/G ratio of 0.58 and a beta of 0.88. The stock’s fifty day simple moving average is $214.96 and its two-hundred day simple moving average is $181.53. DaVita Inc. has a 1-year low of $101.00 and a 1-year high of $247.49.

DaVita (NYSE:DVA) last announced its earnings results on Tuesday, August 4th. The company reported $4.02 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.88 by $0.14. The firm had revenue of $3.55 billion during the quarter, compared to analyst estimates of $3.50 billion. DaVita had a negative return on equity of 217.63% and a net margin of 6.05%.The business’s revenue was up 5.2% compared to the same quarter last year. During the same period last year, the firm posted $2.95 EPS. DaVita has set its FY 2026 guidance at 14.100-15.200 EPS. As a group, analysts forecast that DaVita Inc. will post 14.57 earnings per share for the current fiscal year.

DaVita Company Profile

DaVita Inc (NYSE: DVA) is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.